[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Primary Progressive Multiple Sclerosis Treatment Market Research Report 2012-2024

July 2019 | 88 pages | ID: G6EDC9806E1EN
HeyReport

US$ 2,390.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY


The global Primary Progressive Multiple Sclerosis Treatment market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • ApE
  • Biotin
  • GZ-402668
  • Ibudilast
  • Idebenone
  • Laquinimod Sodium
  • Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • F. Hoffmann-La Roche Ltd.
  • Genzyme Corporation
  • Glialogix, Inc.
  • Kyorin Pharmaceutical Co., Ltd.
  • MedDay SA
  • Santhera Pharmaceuticals Holding AG
  • Teva Pharmaceutical Industries Ltd.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Hospital
  • Clinic
  • Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 ApE
    1.2.1.2 Biotin
    1.2.1.3 GZ-402668
    1.2.1.4 Ibudilast
    1.2.1.5 Idebenone
    1.2.1.6 Laquinimod Sodium
    1.2.1.7 Others
  1.2.2 by Application
    1.2.2.1 Hospital
    1.2.2.2 Clinic
    1.2.2.3 Others
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 ApE Market, 2013-2018
  4.1.2 Biotin Market, 2013-2018
  4.1.3 GZ-402668 Market, 2013-2018
  4.1.4 Ibudilast Market, 2013-2018
  4.1.5 Idebenone Market, 2013-2018
  4.1.6 Laquinimod Sodium Market, 2013-2018
  4.1.7 Others Market, 2013-2018
4.2 Market Forecast
  4.2.1 ApE Market Forecast, 2019-2024
  4.2.2 Biotin Market Forecast, 2019-2024
  4.2.3 GZ-402668 Market Forecast, 2019-2024
  4.2.4 Ibudilast Market Forecast, 2019-2024
  4.2.5 Idebenone Market Forecast, 2019-2024
  4.2.6 Laquinimod Sodium Market Forecast, 2019-2024
  4.2.7 Others Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Hospital Market, 2013-2018
  5.1.2 Clinic Market, 2013-2018
  5.1.3 Others Market, 2013-2018
5.2 Market Forecast
  5.2.1 Hospital Market Forecast, 2019-2024
  5.2.2 Clinic Market Forecast, 2019-2024
  5.2.3 Others Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 F. Hoffmann-La Roche Ltd.
8.2 Genzyme Corporation
8.3 Glialogix, Inc.
8.4 Kyorin Pharmaceutical Co., Ltd.
8.5 MedDay SA
8.6 Santhera Pharmaceuticals Holding AG
8.7 Teva Pharmaceutical Industries Ltd.

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Primary Progressive Multiple Sclerosis Treatment
Table Products Segment of Primary Progressive Multiple Sclerosis Treatment
Table ApE Overview
Table Biotin Overview
Table GZ-402668 Overview
Table Ibudilast Overview
Table Idebenone Overview
Table Laquinimod Sodium Overview
Table Others Overview
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Type, 2011-2022 (USD Million)
Table Application Segment of Primary Progressive Multiple Sclerosis Treatment
Table Hospital Overview
Table Clinic Overview
Table Others Overview
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Application, 2011-2022 (USD Million)
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Region, 2011-2022 (USD Million)
Table Cost of Primary Progressive Multiple Sclerosis Treatment
Table Market Dynamics
Table Policy of Primary Progressive Multiple Sclerosis Treatment
Table GDP of Major Countries
Table ApE CAGR by Revenue and Volume, 2012-2018
Table Biotin CAGR by Revenue and Volume, 2012-2018
Table GZ-402668 CAGR by Revenue and Volume, 2012-2018
Table Ibudilast CAGR by Revenue and Volume, 2012-2018
Table Idebenone CAGR by Revenue and Volume, 2012-2018
Table Laquinimod Sodium CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table ApE CAGR by Revenue and Volume, 2012-2024
Table Biotin CAGR by Revenue and Volume, 2012-2024
Table GZ-402668 CAGR by Revenue and Volume, 2012-2024
Table Ibudilast CAGR by Revenue and Volume, 2012-2024
Table Idebenone CAGR by Revenue and Volume, 2012-2024
Table Laquinimod Sodium CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Hospital CAGR by Revenue and Volume, 2012-2018
Table Clinic CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Vendors, 2012-2018 (USD Million)
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Vendors, 2012-2018 (in Volume)
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share by Vendors, 2012-2018 (USD Million)
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table F. Hoffmann-La Roche Ltd. Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genzyme Corporation Profile List
Table Microecological Modulator Operating Data of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glialogix, Inc. Profile List
Table Microecological Modulator Operating Data of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyorin Pharmaceutical Co., Ltd. Profile List
Table Microecological Modulator Operating Data of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedDay SA Profile List
Table Microecological Modulator Operating Data of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Santhera Pharmaceuticals Holding AG Profile List
Table Microecological Modulator Operating Data of Santhera Pharmaceuticals Holding AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd. Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Primary Progressive Multiple Sclerosis Treatment Picture
Figure Industry Chain Structure of Primary Progressive Multiple Sclerosis Treatment
Figure SWOT of Primary Progressive Multiple Sclerosis Treatment
Figure ApE Market Size and Growth, 2012-2018 (USD Million)
Figure ApE Market Size and Growth, 2012-2018 (in Volume)
Figure Biotin Market Size and Growth, 2012-2018 (USD Million)
Figure Biotin Market Size and Growth, 2012-2018 (in Volume)
Figure GZ-402668 Market Size and Growth, 2012-2018 (USD Million)
Figure GZ-402668 Market Size and Growth, 2012-2018 (in Volume)
Figure Ibudilast Market Size and Growth, 2012-2018 (USD Million)
Figure Ibudilast Market Size and Growth, 2012-2018 (in Volume)
Figure Idebenone Market Size and Growth, 2012-2018 (USD Million)
Figure Idebenone Market Size and Growth, 2012-2018 (in Volume)
Figure Laquinimod Sodium Market Size and Growth, 2012-2018 (USD Million)
Figure Laquinimod Sodium Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Figure ApE Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure ApE Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Biotin Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Biotin Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure GZ-402668 Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure GZ-402668 Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Ibudilast Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Ibudilast Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Idebenone Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Idebenone Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Laquinimod Sodium Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Laquinimod Sodium Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Others Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Others Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Hospital Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Clinic Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Primary Progressive Multiple Sclerosis Treatment Market Concentration by Region
Figure Marketing Channels Overview


More Publications